3B Blackbio Diagnostics Ltd. | Small-cap | Healthcare
₹1,410.35
-0.62%
| 3B Blackbio Stock Comparison:
3B Blackbio vs Biocon3B Blackbio vs OneSource Specialty3B Blackbio vs Dishman Carbogen3B Blackbio vs Zota Health Care3B Blackbio vs Panacea Biotec3B Blackbio vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 222.3M
Gross Profit 166.8M 75.00%
Operating Income 115.6M 51.98%
Net Income 126.4M 56.87%
EPS (Diluted) ₹14.67

Balance Sheet Metrics

Total Assets 3.0B
Total Liabilities 247.1M
Shareholders Equity 2.7B
Debt to Equity 0.09

Cash Flow Metrics

Revenue & Profitability Trend

3B Blackbio Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i964.7M741.2M618.4M806.5M2.3B
Cost of Goods Sold i256.5M218.5M179.2M316.2M515.7M
Gross Profit i708.2M522.8M439.1M490.2M1.8B
Gross Margin % i73.4%70.5%71.0%60.8%77.3%
Operating Expenses
Research & Development i-7.0M8.4M3.6M2.5M
Selling, General & Administrative i-9.9M15.5M8.1M7.3M
Other Operating Expenses i133.9M102.4M66.3M59.3M158.3M
Total Operating Expenses i133.9M119.3M90.3M71.1M168.1M
Operating Income i490.2M322.4M286.3M364.3M1.5B
Operating Margin % i50.8%43.5%46.3%45.2%65.9%
Non-Operating Items
Interest Income i-63.3M38.7M--
Interest Expense i1.1M1.2M2.0M1.1M2.3M
Other Non-Operating Income-----
Pre-tax Income i640.0M443.3M353.1M432.2M1.5B
Income Tax i163.1M122.3M93.7M110.2M381.7M
Effective Tax Rate % i25.5%27.6%26.5%25.5%25.1%
Net Income i476.9M321.0M259.4M322.0M1.1B
Net Margin % i49.4%43.3%41.9%39.9%50.2%
Key Metrics
EBITDA i651.9M396.5M335.9M440.0M1.5B
EPS (Basic) i₹55.66₹37.46₹30.27₹43.40₹151.66
EPS (Diluted) i₹55.66₹37.46₹30.27₹43.40₹151.66
Basic Shares Outstanding i85612118568400856637074918207508100
Diluted Shares Outstanding i85612118568400856637074918207508100

Income Statement Trend

3B Blackbio Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i124.7M129.2M52.4M272.9M338.1M
Short-term Investments i565.6M486.6M532.9M255.6M330.9M
Accounts Receivable i365.2M362.5M339.4M299.8M347.9M
Inventory i87.4M84.3M80.4M74.3M48.7M
Other Current Assets178.9M1.0K129.6M151.5M435.4M
Total Current Assets i1.3B1.2B1.1B815.4M1.2B
Non-Current Assets
Property, Plant & Equipment i72.2M78.9M77.4M69.8M51.4M
Goodwill i00000
Intangible Assets i-----
Long-term Investments-----
Other Non-Current Assets-546.0K-1.0K-4.9M-1
Total Non-Current Assets i1.6B1.2B998.2M1.1B751.4M
Total Assets i3.0B2.5B2.1B1.9B1.9B
Liabilities
Current Liabilities
Accounts Payable i19.7M39.5M33.7M35.4M29.5M
Short-term Debt i0632.0K11.2M16.9M9.9M
Current Portion of Long-term Debt-----
Other Current Liabilities14.3M4.6M3.9M8.5M8.5M
Total Current Liabilities i185.9M175.3M141.8M169.0M429.6M
Non-Current Liabilities
Long-term Debt i3.1M7.9M9.1M8.4M10.2M
Deferred Tax Liabilities i58.2M43.1M29.2M22.7M12.4M
Other Non-Current Liabilities-2.0K1.3M17.0K293.1K
Total Non-Current Liabilities i61.3M51.0M39.6M31.1M22.8M
Total Liabilities i247.1M226.3M181.5M200.2M452.5M
Equity
Common Stock i85.7M85.7M85.7M74.9M74.9M
Retained Earnings i-2.1B1.8B1.4B1.1B
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i2.7B2.3B2.0B1.7B1.5B
Key Metrics
Total Debt i3.1M8.5M20.3M25.3M20.0M
Working Capital i1.1B1.1B1.0B646.4M754.2M

Balance Sheet Composition

3B Blackbio Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i640.0M443.3M353.1M432.2M1.5B
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-21.1M-98.5M-23.8M306.5M-533.5M
Operating Cash Flow i620.0M342.7M331.3M739.8M989.1M
Investing Activities
Capital Expenditures i-9.0M-5.1M-20.2M-22.6M-16.8M
Acquisitions i-----
Investment Purchases i-329.4M-198.1M--338.3M-685.3M
Investment Sales i-0144.6M0-
Investing Cash Flow i-338.5M-203.2M124.9M-360.8M-702.6M
Financing Activities
Share Repurchases i-----
Dividends Paid i-25.7M-21.9M-44.4M-154.6M-
Debt Issuance i--737.0K7.0M-
Debt Repayment i-5.4M-13.1M-5.7M-1.8M-15.2M
Financing Cash Flow i-31.1M-37.0M-48.7M-149.6M-13.4M
Free Cash Flow i424.5M264.4M182.6M350.6M958.4M
Net Change in Cash i250.4M102.5M407.5M229.4M273.2M

Cash Flow Trend

3B Blackbio Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 24.99
Price to Book 4.79
Price to Sales 12.41
PEG Ratio 1.90

Profitability Ratios

Profit Margin 49.51%
Operating Margin 51.98%
Return on Equity 17.58%
Return on Assets 16.11%

Financial Health

Current Ratio 7.11
Debt to Equity 0.11
Beta 0.28

Per Share Data

EPS (TTM) ₹57.42
Book Value per Share ₹299.81
Revenue per Share ₹115.55

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
3bblackbio12.1B24.994.7917.58%49.51%0.11
Biocon 485.5B113.562.013.66%2.44%66.26
OneSource Specialty 214.6B-1,149.263.64-0.31%-0.85%16.03
Dishman Carbogen 43.5B41.510.740.06%3.60%40.97
Zota Health Care 42.2B-72.6537.60-38.38%-20.55%0.61
Panacea Biotec 25.6B217.012.96-1.01%1.88%2.67

Financial data is updated regularly. All figures are in the company's reporting currency.